Global Cord Blood is a diagnostics & research business based in the US. Global Cord Blood shares (CO) are listed on the NYSE and all prices are listed in US Dollars. Global Cord Blood employs 1,202 staff and has a trailing 12-month revenue of around $1.2 billion.
How to buy Global Cord Blood stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Global Cord Blood stock price (NYSE: CO)
Use our graph to track the performance of CO stocks over time.Global Cord Blood shares at a glance
Latest market close | $2.99 |
---|---|
52-week range | $2.03 - $4.08 |
50-day moving average | $2.99 |
200-day moving average | $2.84 |
Wall St. target price | $15.00 |
PE ratio | 5.0637 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $0.59 |
Buy Global Cord Blood stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Global Cord Blood stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Global Cord Blood price performance over time
Historical closes compared with the close of $2.99 from 2023-03-20
1 week (2023-03-14) | 2.99 |
---|---|
1 month (2023-02-22) | 2.99 |
3 months (2022-12-22) | 2.99 |
6 months (2022-09-22) | 34.68% |
1 year (2022-03-22) | -24.87% |
---|---|
2 years (2021-03-22) | -36.11% |
3 years (2020-03-20) | 3.39 |
5 years (2018-03-21) | 11.7528 |
Is Global Cord Blood stock undervalued or overvalued?
Valuing Global Cord Blood stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Cord Blood's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Global Cord Blood financials
Revenue TTM | $1.2 billion |
---|---|
Operating margin TTM | 48.97% |
Gross profit TTM | $1.1 billion |
Return on assets TTM | 4.63% |
Return on equity TTM | 10.99% |
Profit margin | 40.3% |
Book value | $40.14 |
Market capitalisation | $400.1 million |
TTM: trailing 12 months
Global Cord Blood share dividends
We're not expecting Global Cord Blood to pay a dividend over the next 12 months.
Global Cord Blood share price volatility
Over the last 12 months, Global Cord Blood's shares have ranged in value from as little as $2.03 up to $4.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Global Cord Blood's is -0.0417. This would suggest that Global Cord Blood's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Global Cord Blood has bucked the trend.
Global Cord Blood overview
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd. .
Frequently asked questions
What percentage of Global Cord Blood is owned by insiders or institutions?Currently 61.551% of Global Cord Blood shares are held by insiders and 22.154% by institutions. How many people work for Global Cord Blood?
Latest data suggests 1,202 work at Global Cord Blood. When does the fiscal year end for Global Cord Blood?
Global Cord Blood's fiscal year ends in March. Where is Global Cord Blood based?
Global Cord Blood's address is: Bank of China Tower, Central, Hong Kong What is Global Cord Blood's ISIN number?
Global Cord Blood's international securities identification number is: US6986591096 What is Global Cord Blood's CUSIP number?
Global Cord Blood's Committee on Uniform Securities Identification Procedures number is: G39342103
More guides on Finder
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert